Milan: Philogen on the rise
(Teleborsa) - The Developer of biopharmaceutical products for the treatment of life-threatening conditions is doing well with an increase of of 3.29%.A comparison of the security and the FTSE Italia Mid Cap index on a weekly basis shows the greater relative strength of Philogen, confirming a better performance for the security in comparison to the related index.
According to the short-term technicals, Philogen will continue its positive development to test the resistance area of 19.1 Euros. There is the possibility of a decline to the 18.4 low. Overall, we expect the stock to breakout and test new resistance at 19.8.
These analyses are to be considered solely for information purposes and are not in any way intended to constitute financial advice, a solicitation of funds from the public or the promotion of any form of investment.
(Teleborsa Research Department)
(Teleborsa) 05-24-2024 12:30 PM